TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Homeostasis Model Assessment for Insulin Resistance (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Number of General Tonic-clonic Seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumor growth progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: longevity
Endpoint domain: Mortality/survival
Primary endpoint: Area Under the Curve for Oral Glucose Tolerance Test (oGGT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Suspected DVT during follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: Suspected PE during follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of true resistant hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: vasomotor symptoms control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended phase II dose (RP2D) of durvalumab ± tremelimumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Resolution of UTI Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence and severity of dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overall dynamics of hand function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Borg Dyspnea Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Corneal staining test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in antioxidant capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual behavior analysis
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mean pain during intravesical injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement with invasively obtained PCO2 data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety Tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients experiencing all grades of toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Scar width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Self Report Deficits in Daily Life
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Time to first bystander compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating EPC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue EPC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAD7 Score (Anxiety)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to first treatment success (BP <130/80 mm Hg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of solicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained Virologic Response 12 Weeks After Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type and number of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Fluctuations of body temperature
Endpoint domain: Adverse events/effects
Primary endpoint: Apnea
Endpoint domain: Adverse events/effects
Primary endpoint: Bradycardic episode
Endpoint domain: Adverse events/effects
Primary endpoint: Oxygen desaturation episode
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetic parameter (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disabilities of the Arm, Shoulder, and Hand (DASH) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area Under the Curve (AUC) of Testosterone Enanthate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Testosterone Enanthate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Average Concentration (Cavg) of Testosterone Enanthate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Level of inspiratory pressure for gastric insufflation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in energy (vigor) perception
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in exercise performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal bone changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Feasibility of using 18F-Sodium Fluoride for PET bone scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of primary graft rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of Left Ventricular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in lung microbiome profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Gallbladder Ejection Fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Forced Expiratory Volume (1 Second)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced Expiratory Flow (FEF25-75%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Grs change between before and after deep breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of EFV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Pectoralis minor index (PMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Upper Extremity Skills Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peabody Developmental Motor Scale- 2 Fine motor Quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the investigational treatment
Endpoint domain: Adverse events/effects
Primary endpoint: %fT>MIC of meropenem and imipenem
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lot to Lot Consistency of MenACWY as Measured by hSBA GMT Vaccine Group Ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Seroresponders, Ages 11 to 18 Years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With at Least One Severe Systemic Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Sum of the moments of strength developed by the plantar flexor and dorsiflexor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean total displacement of the Centre of Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed Objective Response Rate (ORR)
Endpoint domain: Mortality/survival
Primary endpoint: 12 Months Progression-Free Survival (PFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: muscle fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuation Rates of the LNG-IUS
Endpoint domain: Adverse events/effects
Primary endpoint: Post-prandial blood glucose area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Receipt of colorectal cancer screening exam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant knowledge enhancement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Spleen Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myocardial work
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with tachycardia after intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ECGs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in constant shoulder score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change of pain intensity score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change of clinical symptoms as respiratory distress or need for oxygen support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of cytokine storm parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of pulmonary functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of diabetic macular edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve at Steady State (AUCtau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Serum Concentration at Steady State (Cmax,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate (ORR) According to the 1999 International Working Group (IWG) Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Pathologic Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lower extremity function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in turnout
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Change Since Baseline in Numerical Rating Scale (NRS) for Pain (Overall)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of confocal endomicroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering of insulin-dependence and anti-hyperglycemic medication dosages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in reaction time (Emotional Stroop)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in task completion time (Trail-Making Task A)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in task completion time (Trail-Making Task B)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in translated symbols (Digit Symbol Substitution)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in response accuracy (Little Man Task)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in response accuracy (Wisconsin Card Sorting Task)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cyst recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SIRI Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in integrity and healing of meniscus repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Yale-Brown Obsessive Compulsive Scale for Pathological Gambling (PG-YBOCS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients who withdraw due to Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Adverse Events and Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical significance/ changes in laboratory parameters over time (study period)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Plasmodium falciparum gametocytes and/or asexual blood stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: live birth rate of a healthy baby
Endpoint domain: Mortality/survival
Primary endpoint: aerobic conditioning (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insulin sensitivity (HOMA-index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline physical condition of joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline perception of the quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change From Baseline in Body Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events (AEs), Serious Adverse Events (SAEs), and Withdrawals Due to AEs (Except Hemophilia AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Time taken for Blood Pressure control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent Probability of Pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Achieving HiSCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Safety of study drug during and following infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Impact of SANGUINATE on brain oxygenation and blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Scar Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impedance values with ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary vein isolation line gaps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: StO2 recovery slope (recStO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calcium metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Local signs of infection
Endpoint domain: Adverse events/effects
Primary endpoint: Response time before detection of stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Value of the PDR (Percentage Dose Recovery of 13C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in clinical laboratory hematology tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in clinical laboratory chemistry tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain/Function as measured by the SPADI outcome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprocedural Shivering
Endpoint domain: Adverse events/effects
Primary endpoint: Tibial Nerve Cross-Sectional Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: plasma levels of nesfatin-1, nicotinamide and dopamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall response rate (complete and partial responses)
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of EGFR mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in Total Nasal Symptom Score (TNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Experience at Least One Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Number of Adherent Sets of Symbicort Puffs Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage change in gross tumor volume (GTV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Difference in mean gross tumor volume (GTV), assessed using the RECIST method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Difference in tumor grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Ability to Perceive Negative and Positive Emotional Expressions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Emotion Perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in vertical and horizontal lip length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in lip defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-discharge length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cardiac-related specialist outpatient clinic visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PTSD diagnoses and symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Evaluation of Negative Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Kentucky Inventory of Mindfulness Skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pain (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Outcome of Success of Injection Assessed by Survey Question
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of analysis of aortic regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vascularisation in thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Patients With Successful Study Drug Administrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment-related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Ventilator Free Days at Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total salpingectomy time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Wound Healing by Numerical Scales for Rubor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Healing by Numerical Scales for Secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Healing by Numerical Scales for Oedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Live Birth
Endpoint domain: Mortality/survival
Primary endpoint: modified Yale Preoperative Anxiety Scale (mYPAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum tolerated dose of CCT303-406
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mindfulness ability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Optical Coherence Tomography (OCT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl Meyer Upper Extremity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overactive Bladder Symptom Score (OABSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knowledge of head and neck cancer procedures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Subjects Completing 24 Weeks Adjunctive Therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: improvement of esophageal barium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Predictive model's area under curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants in Which H. Pylori Was Eradicated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in response to Chloride-free solution and isoproterenol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of Oral lichen planus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postoperative sore throat at rest
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of postoperative sore throat at swallowing
Endpoint domain: Adverse events/effects
Primary endpoint: severity of postoperative sore throat at rest
Endpoint domain: Adverse events/effects
Primary endpoint: severity of postoperative sore throat at swallowing
Endpoint domain: Adverse events/effects
Primary endpoint: Average number of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Oxygenation Saturation Index (OSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes